Modelling associations between time-to-event responses in pilot cancer clinical trials using a Plackett-Dale model

Statistics in Medicine

Volumn 23, Issue 14, 2004, Pages 2173-2186

  Tibaldi, Fabián ^a   Torres Barbosa, Franz ^b   Molenberghs, Geert ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

Author keywords

Copula models; Plackett Dale; Pseudo likelihood; Surrogates

Indexed keywords

CANCER VACCINE; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR;

ADULT; ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PATIENT; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; HUMAN; IMMUNOGENICITY; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; ONCOLOGY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; STATISTICAL PARAMETERS; SURVIVAL TIME; TIME SERIES ANALYSIS; TREATMENT OUTCOME; VALIDATION PROCESS;

ADJUVANTS, IMMUNOLOGIC; BIOLOGICAL MARKERS; CANCER VACCINES; CARCINOMA, NON-SMALL-CELL LUNG; EPIDERMAL GROWTH FACTOR; HUMANS; LIKELIHOOD FUNCTIONS; LUNG NEOPLASMS; MIDDLE AGED; MODELS, IMMUNOLOGICAL; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; PILOT PROJECTS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS;

EID: 3242804485     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1820     Document Type: Article

References (39)

1. Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumour response. Journal of Clinical Oncology 1983; 1:710-719.
2. Ellenberg SS, Hamilton JM. Surrogate endpoints in clinical trials: cancer. Statistics in Medicine 1989; 8: 405-413.
3. Buyse M, Molenberghs G. The validation of surrogate endpoints in randomized experiments. Biometrics 1998; 54:186-201.
4. Prentice RL. Surrogate endpoints in clinical trials: definitions and operational criteria. Statistics in Medicine 1989; 8:431-440.
5. Freedman LS, Graubard BI, Schatzkin A. Statistical validation of intermediate endpoints for chronic diseases. Statistics in Medicine 1992; 11:167-178.
6. Fleming TR, DeMets DL. Surrogate endpoints in clinical trials: are we being misled? Annals of Internal Medicine 1996; 125:605-613.
7. Buyse M, Molenberghs G, Burzykowski T, Renard D, Geys H. The validation of surrogate endpoints in meta-analyses of randomized experiments. Biostatistics 2000; 1:1-19.
8. Verbeke G. Molenberghs G. Linear Mixed Model for Longitudinal Data. Springer: New York, 2000.
9. Tibaldi F, Cortiñas Abrahantes J, Molenberghs G, Renard D, Burzykowski T, Buyse M, Parmar M, Stijnen T, Wolfinger R. Simplified hierarchical linear models for the evaluation of surrogate endpoints. Journal of Statistical Computation and Simulation 2003; 73:643-658.
10. Burzykowski T, Molenberghs G, Buyse M, Geys H, Renard D. Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpoints. Applied Statistics 2001; 50:405-422.
11. Tibaldi F, Molenberghs G, Burzykowski T, Geys H. Pseudo-likelihood estimation for a marginal multivariate survival model. Statistics in Medicine 2004; 23:947-963.
12. . González G, Crombet T, Catalá M, Mirabal V, Hernández J, González Y, Marinello P, Guillén G, Lage A. A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial. Annals of Oncology 1998; 9:431-435.
13. González G, Crombet T, Torres F, Catalá M, Alfonso L, Osorio M, Neninger E, García B, Mulet A, Pérez R, Lage A. Epidermal growth factor based cancer vaccine for non small cell lung cancer therapy. Annals of Oncology 2003; 14:461-466.
14. Torres F, Gonzàlez G, Crombet T, Lage A. Empirical Bayes analysis of early clinical trials for cancer vaccines. 2003; (in revision).
15. Torres F, Tibaldi F, Cortiñas Abrahantes J, Geys H, González G, Molenberghs G. Surrogacy evaluation of immunological parameters in pilot cancer clinical trials. 2003; (in revision).
16. Lipsitz SR, Laird NM, Harrington DP. Generalized estimating equations for correlated binary data: using the odds ratio as a measure of association. Biometrika 1991; 78:153-160.
17. Dale JR. Global cross-ratio models for bivariate, discrete, ordered responses. Biometrics 1986; 42:909-917.
18. Molenberghs G, Lesaffre E. Marginal modelling of correlated ordinal data using a multivariate Plackett distribution. Journal of the American Statistical Association 1994; 89:633-644.
19. Glonek GFV, McCullagh P. Multivariate logistic models. Journal of the Royal Statistical Society, Series B 1995; 57:533-546.
20. Lang JB, Agresti A. Simultaneously modeling joint and marginal distributions of multivariate categorical responses. Journal of the American Statistical Association 1994; 89:625-632.
21. Geys H, Molenberghs G, Ryan L. Pseudo-likelihood modelling of multivariate outcomes in developmental toxicology. Journal ot the American Statistical Association 1999; 94:34-745.
22. Plackett RL. A class of bivariate distributions. Journal of the American Statistical Association 1965; 60: 516-522.
23. Mardia KV. Families of Bivariate Distributions. Griffin: London, 1970.
24. Arnold BC, Strauss D. Pseudo likelihood estimation: some examples. Sankhya B 1991; 53:233-243.
25. Le Cessie S, Van Houwelingen JC. Logistic regression for correlated binary data. Applied Statistics 1994; 43: 95-108.
26. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 50:13-22.
27. Genest C, McKay J. The joy of copulas: bivariate distributions with uniform marginals. American Statistician 1986; 40:280-283.
28. Schweizer B, Wolff EF. On nonparametric measures of dependence for random variables. Annals of Statistics 1981; 9:879-885.
29. Buyse M, Thirion P, Carlson RW, Burzykowski T, Molenberghs G, Piedbois P. Tumour response to first line chemotherapy improves the survival of patients with advanced colorectal cancer. Lancet 2000; 356:373-378.
30. Burzykowski T, Molenberghs G, Buyse M. The validation of surrogate endpoints using data from randomized clinical trials: a case study in advanced colorectal cancer. Journal of the Royal Statistical Society A 2001; 167:103-124.
31. Green S, Benedetti J, Crowley J. Clinical Trials in Oncology (2nd edn). Chapman & Hall: London; CRC: Boca Raton, FL, 2003.
32. Nelsen RG. An introduction to copulas. Lecture Notes in Statistics, vol. 139. Springer: New York, 1999.
33. Cox DR. Regression models in life-tables (with discussion). Journal of the Royal Statistical Society, Series B 1972; 34:187-220.
34. Lehmann EL. Theory of Point Estimation. Wiley: New York, 1983.
35. Shih JH, Louis TA. Inferences on association parameter in copula models for bivariate survival data. Biometrics 1995; 51:1384-1399.
36. Fréchet M. Sur les tableaux de corrélation dont les marges sont données. Annals Université de Lyon, Section A, Series 3 1951; 14:143-153.
37. Aerts M, Geys H, Molenberghs G, Ryan L. Topics in Modelling of Clustered Data. Chapman & Hall: London, 2002.
38. Molenberghs G, Lesaffre E. Marginal modelling of multivariate categorical data. Statistics in Medicine 1999; 18:2237-2255.
39. Joe H. Multivariates Models and Dependence Concepts. Chapman & Hall: London, 1997.